Finance and Economics

Much of my writing is in finance and economics. The fit is comfortable, given my educational background and the number of times I've had to undertake financial modeling in my career.

Investor Alert: How to See Through Corporate Earnings Smoke and Mirrors

In August 2015, pharmaceutical company Valeant was riding high. By late October, the company would lose nearly $60 billion in market value. Now, after greater scrutiny and criticism, Valeant's stock is down more than 85 percent from its high. A major cause of the rise — and the fall — was so-called pro forma results. Companies can use measures other than generally accepted accounting principles, or GAAP, the gold standard for U.S. accounting, to report results so long as they also include the GAAP measures.
Close